Table 1.
Number of signals by percentage of analyzed nuclei
| Case | Age (yr) | Origin | HT | UICC | Immunostaining | Probe |
Percentage of nuclei |
||||||
|
Number of signals | |||||||||||||
| 1 | 2 | 3 | 4 | 5 | ≥ 6 | HA | |||||||
| 1 | 77 | Antrum | Intestinal | T2N1M0 | Nuclear | C-MYC | 0 | 34 | 23 | 25 | 14 | 2 | 2 |
| Chrom.8 | 0 | 58 | 33 | 9 | 0 | 0 | - | ||||||
| 2 | 48 | Antrum | Intestinal | T4N0M0 | Nuclear | C-MYC | 0 | 35 | 10 | 20 | 29 | 2 | 4 |
| Chrom.8 | 0 | 70 | 21 | 6 | 3 | 0 | - | ||||||
| 3 | 74 | Antrum | Diffuse | T1N0M0 | Nuclear/Cytoplasmatic | C-MYC | 1 | 38 | 29 | 30 | 2 | 0 | 0 |
| Chrom.8 | 2 | 59 | 19 | 18 | 2 | 0 | - | ||||||
| 4 | 74 | Antrum/body | Intestinal | T4N0M0 | Nuclear | C-MYC | 0 | 40 | 12 | 28 | 17 | 2 | 1 |
| Chrom.8 | 0 | 63 | 25 | 1 | 1 | 0 | - | ||||||
| 5 | 41 | Antrum | Intestinal | T2N0M0 | Nuclear | C-MYC | 0 | 36 | 18 | 30 | 13 | 2 | 1 |
| Chrom.8 | 4 | 61 | 30 | 4 | 1 | 0 | - | ||||||
| 6 | 56 | Antrum/body | Diffuse | T2N1M0 | Nuclear/Cytoplasmatic | C-MYC | 0 | 31 | 38 | 17 | 14 | 0 | 0 |
| Chrom.8 | 3 | 60 | 32 | 5 | 1 | 0 | - | ||||||
| 7 | 55 | Antrum | Intestinal | T4N2M1 | Nuclear | C-MYC | 2 | 48 | 27 | 7 | 7 | 3 | 6 |
| Chrom.8 | 2 | 54 | 27 | 5 | 4 | 8 | |||||||
| Control | 77 | Stomach tissue | - | - | Without staining | C-MYC | 2 | 98 | 0 | 0 | 0 | 0 | 0 |
| Chrom.8 | 1 | 96 | 3 | 0 | 0 | 0 | - | ||||||
| Control | 37 | Lymphocytes | - | - | Without staining | C-MYC | 0.5 | 99.5 | 0 | 0 | 0 | 0 | 0 |
| Chrom.8 | 1 | 98.5 | 0.5 | 0 | 0 | 0 | - | ||||||
HT: Histological type; UICC: Union Internationale Contre le Cancer; HA: High amplification.